Encompass Health Corp banner

Encompass Health Corp
NYSE:EHC

Watchlist Manager
Encompass Health Corp Logo
Encompass Health Corp
NYSE:EHC
Watchlist
Price: 112.21 USD -0.25% Market Closed
Market Cap: $11.1B

Wall St Price Targets

EHC Price Targets Summary
Encompass Health Corp

Wall Street analysts forecast EHC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EHC is 143.31 USD with a low forecast of 126.25 USD and a high forecast of 159.6 USD.

Lowest Forecast
Price Target
126.25 USD
13% Upside
Average Forecast
Price Target
143.31 USD
28% Upside
Highest Forecast
Price Target
159.6 USD
42% Upside
Encompass Health Corp Competitors:
Price Targets

Revenue
Forecast

8% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
8% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is 9%.

Gross Profit
Forecast

8% / Year
Past Growth
-4% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
8% / Year
Past Growth
-4% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 4 years is -4%.

Operating Income
Forecast

7% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
7% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 3 years is 6%.

Pre-Tax Income
Forecast

8% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
8% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 4%.

Net Income
Forecast

10% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
10% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 5 years is 12%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is EHC's stock price target?
Price Target
143.31 USD

According to Wall Street analysts, the average 1-year price target for EHC is 143.31 USD with a low forecast of 126.25 USD and a high forecast of 159.6 USD.

What is the Revenue forecast for Encompass Health Corp?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is 9%.

What is the Gross Profit forecast for Encompass Health Corp?
Projected CAGR
-4%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 4 years is -4%.

What is the Operating Income forecast for Encompass Health Corp?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 3 years is 6%.

What is the Pre-Tax Income forecast for Encompass Health Corp?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 4%.

What is the Net Income forecast for Encompass Health Corp?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 5 years is 12%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett